University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.
Université Clermont Auvergne, Inserm, CHU Clermont-Ferrand, 3iHP, Service d'Hépato-Gastro Entérologie, Clermont-Ferrand, France.
Inflamm Bowel Dis. 2021 Jun 15;27(7):1008-1016. doi: 10.1093/ibd/izaa269.
As the reliability of fecal calprotectin (Fcal) remains debatable to detect endoscopic ulcerations in patients with pure ileal Crohn's disease (CD), we aimed to compare its performances with those observed in patients with colonic or ileocolonic location.
Using a prospectively maintained database, we analyzed 123 CD patients with Fcal measurement and ileocolonoscopy performed within 1 month with no therapeutic intervention during this interval. Receiver operating characterstic curves (ROC) were used to determine the best Fcal threshold to detect endoscopic ulcerations, taking into account the clinical relevance and usual recommended indices. Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were presented with 95% confidence intervals.
The mean Fcal level was significantly higher in patients with endoscopic ulcerations in the L1 group (P = 0.025) and the L2-L3 group (P < 0.001). Using ROC curves, Fcal >200 µg/g and Fcal >250 µg/g were the best thresholds to detect endoscopic ulcerations in the L1 group (sensitivity = 75.0, 95% CI, 47.6-92.7; specificity = 87.5, 95% CI, 67.6-97.3; PPV = 80.0, 95% CI, 51.9-95.7; and NPV = 84.0; 95% CI, 63.9-95.5) and in the L2-L3 group (sensitivity = 84.1 95% CI, 69.9-93.4; specificity = 74.4, 95% CI, 57.9-87.0; PPV = 78.7, 95% CI, 64.3-89.3, and NPV = 80.6, 95% CI, 64.0-91.8), respectively. We compared the AUC between L1 and L2-L3 groups, and no difference was shown (0.89 vs 0.84, respectively, P = 0.46). We also compared 2-by-2 sensitivity, specificity, PPV, NPV, and accuracy and we did not observe any significant difference.
Fecal calprotectin is highly effective to detect endoscopic ulcerations regardless of CD location but requires a lower cutoff value in patients with pure ileal involvement.
粪便钙卫蛋白(Fcal)的可靠性仍存在争议,无法用于检测单纯回肠克罗恩病(CD)患者的内镜下溃疡,因此我们旨在比较其在结肠或回结肠病变患者中的表现。
使用前瞻性维护的数据库,我们分析了 123 例接受 Fcal 测量和结肠镜检查的 CD 患者,这些患者在 1 个月内接受了治疗,并且在此期间没有进行任何治疗干预。我们使用接受者操作特征曲线(ROC)来确定检测内镜下溃疡的最佳 Fcal 阈值,同时考虑到临床相关性和常用推荐指标。我们用 95%置信区间(CI)表示敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。
在 L1 组(P = 0.025)和 L2-L3 组(P < 0.001)中,内镜下有溃疡的患者的 Fcal 水平显著较高。使用 ROC 曲线,Fcal >200 µg/g 和 Fcal >250 µg/g 是 L1 组(敏感性=75.0,95%CI,47.6-92.7;特异性=87.5,95%CI,67.6-97.3;PPV=80.0,95%CI,51.9-95.7;NPV=84.0;95%CI,63.9-95.5)和 L2-L3 组(敏感性=84.1,95%CI,69.9-93.4;特异性=74.4,95%CI,57.9-87.0;PPV=78.7,95%CI,64.3-89.3;NPV=80.6,95%CI,64.0-91.8)检测内镜下溃疡的最佳阈值,其敏感性、特异性、PPV、NPV 和准确性的 AUC 之间无显著差异。
无论 CD 位置如何,粪便钙卫蛋白对检测内镜下溃疡均具有高度有效性,但在单纯回肠受累的患者中需要较低的截止值。